Candx Holdings Limited agreed to acquire a 31.96% stake in Cytogen, Inc. (KOSDAQ:A217330) from Jeon Byung Hee and others for KRW 110 billion on December 19, 2023. Transaction is financed through it's own funds.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
11,750 KRW | +4.91% | +1.29% | -13.09% |
1st Jan change | Capi. | |
---|---|---|
-13.09% | 183M | |
-27.01% | 10.26B | |
+31.86% | 3.04B | |
-8.58% | 2.94B | |
-13.62% | 2.19B | |
-16.32% | 1.72B | |
+63.36% | 1.4B | |
+27.00% | 780M | |
-2.18% | 736M | |
-19.18% | 560M |
- Stock Market
- Equities
- A217330 Stock
- News Cytogen, Inc.
- Candx Holdings Limited agreed to acquire a 31.96% stake in Cytogen, Inc. from Jeon Byung Hee and others for KRW 110 billion